202 related articles for article (PubMed ID: 34658364)
1. Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma.
Eckardt L; Prange-Barczynska M; Hodson EJ; Fielding JW; Cheng X; Lima JDCC; Kurlekar S; Douglas G; Ratcliffe PJ; Bishop T
Endocr Relat Cancer; 2021 Oct; 28(12):757-772. PubMed ID: 34658364
[TBL] [Abstract][Full Text] [Related]
2. Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.
López-Jiménez E; Gómez-López G; Leandro-García LJ; Muñoz I; Schiavi F; Montero-Conde C; de Cubas AA; Ramires R; Landa I; Leskelä S; Maliszewska A; Inglada-Pérez L; de la Vega L; Rodríguez-Antona C; Letón R; Bernal C; de Campos JM; Diez-Tascón C; Fraga MF; Boullosa C; Pisano DG; Opocher G; Robledo M; Cascón A
Mol Endocrinol; 2010 Dec; 24(12):2382-91. PubMed ID: 20980436
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway.
Hodson EJ; Nicholls LG; Turner PJ; Llyr R; Fielding JW; Douglas G; Ratnayaka I; Robbins PA; Pugh CW; Buckler KJ; Ratcliffe PJ; Bishop T
J Physiol; 2016 Mar; 594(5):1179-95. PubMed ID: 26337139
[TBL] [Abstract][Full Text] [Related]
4. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K
J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster.
Fliedner SM; Shankavaram U; Marzouca G; Elkahloun A; Jochmanova I; Daerr R; Linehan WM; Timmers H; Tischler AS; Papaspyrou K; Brieger J; de Krijger R; Breza J; Eisenhofer G; Zhuang Z; Lehnert H; Pacak K
Neoplasia; 2016 Sep; 18(9):567-76. PubMed ID: 27659016
[TBL] [Abstract][Full Text] [Related]
6. Myeloid PHD2 deficiency accelerates neointima formation via Hif-1α.
Christoph M; Pfluecke C; Mensch M; Augstein A; Jellinghaus S; Ende G; Mierke J; Franke K; Wielockx B; Ibrahim K; Poitz DM
Mol Immunol; 2022 Sep; 149():48-58. PubMed ID: 35724581
[TBL] [Abstract][Full Text] [Related]
7. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
[TBL] [Abstract][Full Text] [Related]
8. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
Zhao Y; Zeng H; Liu B; He X; Chen JX
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
[TBL] [Abstract][Full Text] [Related]
9. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
[TBL] [Abstract][Full Text] [Related]
10. Decreased prolyl hydroxylase 3 mRNA expression in oncocytomas compared with clear cell renal cell carcinoma.
Kampantais S; Kounatidis I; Kotoula V; Vakalopoulos I; Gkagkalidis K; Dimitriadis G
Int J Biol Markers; 2020 Dec; 35(4):80-86. PubMed ID: 33118406
[TBL] [Abstract][Full Text] [Related]
11. Loss of Endothelial Hypoxia Inducible Factor-Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis.
Dai Z; Cheng J; Liu B; Yi D; Feng A; Wang T; An L; Gao C; Wang Y; Zhu MM; Zhang X; Zhao YY
J Am Heart Assoc; 2021 Nov; 10(22):e022077. PubMed ID: 34743552
[TBL] [Abstract][Full Text] [Related]
12. Silencing of HIF prolyl-hydroxylase 2 gene in the renal medulla attenuates salt-sensitive hypertension in Dahl S rats.
Zhu Q; Hu J; Han WQ; Zhang F; Li PL; Wang Z; Li N
Am J Hypertens; 2014 Jan; 27(1):107-13. PubMed ID: 24190904
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
[TBL] [Abstract][Full Text] [Related]
14. PHD2 inactivation in Type I cells drives HIF-2α-dependent multilineage hyperplasia and the formation of paraganglioma-like carotid bodies.
Fielding JW; Hodson EJ; Cheng X; Ferguson DJP; Eckardt L; Adam J; Lip P; Maton-Howarth M; Ratnayaka I; Pugh CW; Buckler KJ; Ratcliffe PJ; Bishop T
J Physiol; 2018 Jun; 596(18):4393-412. PubMed ID: 29917232
[TBL] [Abstract][Full Text] [Related]
15. The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.
Peng S; Zhang J; Tan X; Huang Y; Xu J; Silk N; Zhang D; Liu Q; Jiang J
Front Endocrinol (Lausanne); 2020; 11():586857. PubMed ID: 33329393
[TBL] [Abstract][Full Text] [Related]
16. Tight control of hypoxia-inducible factor-α transient dynamics is essential for cell survival in hypoxia.
Bagnall J; Leedale J; Taylor SE; Spiller DG; White MR; Sharkey KJ; Bearon RN; Sée V
J Biol Chem; 2014 Feb; 289(9):5549-64. PubMed ID: 24394419
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
Wang Z; Zhu Q; Xia M; Li PL; Hinton SJ; Li N
Hypertension; 2010 May; 55(5):1129-36. PubMed ID: 20308610
[TBL] [Abstract][Full Text] [Related]
18. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
19. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia Inducible Factor-2 Alpha and Prolinhydroxylase 2 Polymorphisms in Patients with Acute Respiratory Distress Syndrome (ARDS).
Dötsch A; Eisele L; Rabeling M; Rump K; Walstein K; Bick A; Cox L; Engler A; Bachmann HS; Jöckel KH; Adamzik M; Peters J; Schäfer ST
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28613249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
